On 27 September 2022 the second edition of Leiden Drug Development Conference (LDDC) will be organised by LUMC, Leiden University, Janssen, Galapagos and TNO.
Which technologies and innovations will radically change the research and development of medicines in the future? And how can we make medicines and vaccines, while the conditions within which we do this, are deteriorating? We want to discuss the complexity of the development, production and distribution of medicines.
Computational science, prevention, federated data networks and anti-infectives. The future of drug development is the main topic on the agenda. During this conference leading scientists and professionals will tell you the latest in their research field. And our keynote speaker Paul Stoffels (CEO Galapagos) will give his view on the topic.
The aim is to actively connect business and science, discover how we can reinforce each other, and work together on the future of life sciences and health.
Join us on 27 September and meet up with other professionals! Click here for the program or to register.